Market closedNon-fractional

Biora Therapeutics/BIOR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Biora Therapeutics

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Ticker

BIOR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

58

BIOR Metrics

BasicAdvanced
$24M
Market cap
-
P/E ratio
-$5.45
EPS
1.23
Beta
-
Dividend rate
$24M
1.23
0.275
0.228
-43.78
-47.276
-6.78%
-110.05%
108.28%
25.291
-0.2
-0.19
-0.281
172.00%
11.23%
-67.93%
-65.08%

What the Analysts think about BIOR

Analyst Ratings

Majority rating from 1 analysts.
Buy

BIOR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-820.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$500K
∞%
Net income
-$4.1M
-73.38%
Profit margin
-820.00%
-∞%

BIOR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 68.89%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.47
-$4.89
-$0.62
-$0.14
-
Expected
-$1.60
-$0.93
-$0.60
-$0.45
-$0.45
Surprise
-8.13%
428.65%
4.20%
-68.89%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Biora Therapeutics stock?

Biora Therapeutics (BIOR) has a market cap of $24M as of July 06, 2024.

What is the P/E ratio for Biora Therapeutics stock?

The price to earnings (P/E) ratio for Biora Therapeutics (BIOR) stock is 0 as of July 06, 2024.

Does Biora Therapeutics stock pay dividends?

No, Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Biora Therapeutics dividend payment date?

Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders.

What is the beta indicator for Biora Therapeutics?

Biora Therapeutics (BIOR) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Biora Therapeutics stock

Buy or sell Biora Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing